Liability threshold model for nsCL/P. by Laurence J. Howe (5579186)

Subjects:

Lactic acid decreases extra- and intracellular pH. by Yiwen Xiang (360073)

1,25D and phosphate treatment of Ocy454 cells decreases expression of genes implicated in perilacunar matrix resorption. by Ye Yuan (531126)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 12 covariates chosen using subjective feature selection. by Dennis Ochola (11626912)

Predictions of random forests (RF), gradient boosting machines (GBM), and neural networks (NN) trained on 17 covariates selected after recursive feature selection. by Dennis Ochola (11626912)

PAI-1 decreased Shh induced tube formation. by Hua Teng (177804)

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

Que decreases the number of infiltrating T cells in spinal cord. by Feng Mei (143817)

“…Quantification of the staining is depicted in the bar graphs (<b>D and H</b>). Scale bar <b>A–G</b> = 0.5 mm, <b>F’</b> = 50 µm.</p>…”

Loss of Sidt2 decreased insulin granule exocytosis. by Jialin Gao (420257)

Decreased number of cilia in partially formed KV lumen. by Jeong-gyun Kim (4330168)

Sodium chlorate and heparinase treatment decreases cell fusion. by Mary M. Melia (623496)

Decreased immunoreactivity of MMP-9 in LBP-treated brain. by Di Yang (126672)

Diclofenac decreases glucose consumption and modulates lactate accumulation. by Eva Gottfried (431785)

Rat LIPC sera decreased ROS in H₂O₂-injured HUVECs. by Min Chen (147733)

Decreased immunoreactivity of AQP4 in LBP-treated brain. by Di Yang (126672)

“…<p>(A–C) AQP4 IHC signals in swollen end-feet of astrocytes around cerebral vessels in ipsilateral penumbral areas (interaural 1.98 mm). …”

BSO and AUR decreased cell viability and clonogenic survival. by Arya Sobhakumari (300950)

2-NBDG₆₀ is sensitive to a decrease in blood glucose levels. by Narasimhan Rajaram (474255)

“…<p><b>A</b>. Representative 2-NBDG kinetic profiles for 3 different fasting groups of mice after injection of a 6 mM (2mg/ml) dose via the tail-vein. …”

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)